|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating activities: | |||||
| Net (loss) income | |||||
| Adjustments to reconcile net (loss) income to net cash provided by operating activities: | |||||
| Depreciation, depletion and amortization | |||||
| Amortization of acquired intangibles | |||||
| Amortization of debt issuance costs and accretion of debt discount | |||||
| Loss on extinguishment of debt | |||||
| Mark-to-market adjustment for acquisition-related obligations | |||||
| Loss (gain) on disposal of assets, net | |||||
| Accretion on asset retirement obligations | |||||
| Employee benefit plans, net | |||||
| Deferred tax (benefit) expense | |||||
| Stock-based compensation | |||||
| Equity loss in affiliates | |||||
| Other, net | |||||
| Changes in operating assets and liabilities | |||||
| Trade accounts receivable, net | |||||
| Inventories, net | |||||
| Prepaid expenses and other current assets | |||||
| Deposits | |||||
| Other non-current assets | |||||
| Trade accounts payable | |||||
| Accrued expenses and other current liabilities | |||||
| Acquisition-related obligations | |||||
| Workers’ compensation and black lung obligations | |||||
| Pension obligations | |||||
| Asset retirement obligations | |||||
| Other non-current liabilities | |||||
| Net cash provided by operating activities | |||||
| Investing activities: | |||||
| Capital expenditures | |||||
| Capital contributions to equity affiliates | |||||
| Proceeds from disposal of assets | |||||
| Cash paid for business acquired | |||||
| Purchases of investment securities | |||||
| Sales and maturities of investment securities | |||||
| Other, net | |||||
| Net cash used in investing activities | |||||
| Financing activities: | |||||
| Repurchases of long-term debt | |||||
| Principal repayments of long-term debt | |||||
| Principal repayments of financing lease obligations | |||||
| Common stock repurchases and related expenses | |||||
| Proceeds from exercise of warrants | |||||
| Other, net | |||||
| Net cash used in financing activities | |||||
| Net (decrease) increase in cash and cash equivalents and restricted cash | |||||
| Cash and cash equivalents and restricted cash at beginning of period | |||||
| Cash and cash equivalents and restricted cash at end of period | |||||
| Supplemental cash flow information: | |||||
| Cash paid for interest | |||||
| Cash paid for income taxes | |||||
| Cash received for income tax refunds | |||||
| Cash paid for income taxes (net of refunds received) | |||||
| Total cash paid for income taxes | |||||
| Supplemental disclosure of noncash investing and financing activities: | |||||
| Financing leases and capital financing - equipment | |||||
| Accrued capital expenditures | |||||
| Accrued common stock repurchases and stock repurchase excise tax | |||||
| Accrued dividend payable | |||||
| Cash and cash equivalents | |||||
| Short-term restricted cash | |||||
| Long-term restricted cash | |||||
Loading...